Richard Godfrey joined BerGenBio(@BGenBio) as CEO in 2008, he has extensive international drug development and commercial experience.
— Sachs Associates (@SachsAssociates) February 11, 2021
e-Meet Richard at #Sachs_ELSF
More info @ https://t.co/YXBF2fUYBz pic.twitter.com/XErU4mUfR2